Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Are balance scales affected by fear of falling? – a Delphi methodology study
Movement Disorders
P8 - Poster Session 8 (8:00 AM-9:00 AM)
3-005

To identify the items -from commonly used balance scales- that are sensitive to fear of falling.

Falls are a common cause for morbidity and mortality worldwide. Risk of falling is usually assessed by validated balance scales. However, it is unclear how much the patient’s fear of falling could affect the results of these scales. Also, we do not understand which items within commonly used balance scales are sensitive or resistant to fear.

We evaluated 48 balance tasks including those in the Tinetti’s Assessment Tool, Berg Balance Scale, Dynamic Gait Index and Functional Gait Assessment scales, the timed ‘Up & Go’, retropulsive pull, unipedal stance, functional reach and the sit-to-stand x5 tests. We used the Delphi methodology with 3 rounds. The 13 reviewers were selected to include a wide array of expertise in balance and fear. For each of the 48 items, the reviewers were asked to reflect on how fear of falling would affect the performance of that task. We measured quantitatively the responses, and progress through the multiple Delphi rounds. Strict pre-specified criteria were established to determine if consensus was reached.

All 13 participants completed the 3 Delphi rounds. Of them, 8 tasks were found to be resistant to fear of falling while 22 tasks were highly sensitive to fear of falling. For the rest 18 tasks, either they were found to be intermediate or consensus could not be reached for them.

The most important outcome of this work will be the creation of balance scales that are not affected by fear of falling. Also, objective measurements of fear of falling are needed. Work is underway to validate a sub-scale within Berg’s Balance Scale that will help identify fear of falling
Authors/Disclosures
Diego Torres-Russotto, MD, FÂé¶¹´«Ã½Ó³»­ (Miami Neuroscience Institute - Baptist Health South Florida)
PRESENTER
Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anneal. Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC.
James Y. Shou, MD (Rochester General Hospital) No disclosure on file
Nabeel M. Syed, MBBS (Shifa International Hospital) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Amy Hellman, MD, FÂé¶¹´«Ã½Ó³»­ (University of Nebraska Medical Center) The institution of Dr. Hellman has received research support from COBRE-NIH. The institution of Dr. Hellman has received research support from Neurocrine.
Luis E. Zayas, MD (GEM Neurology PLLC) No disclosure on file
Rebecca J. Thompson, MD (Dartmouth-Hitchcock Medical Center Dept of Neurology) No disclosure on file
No disclosure on file
Ryan T. Brennan, DO (Medical College of Wisconsin) Dr. Brennan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
John M. Bertoni, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (University of Nebraska Medical Center) Dr. Bertoni has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
Danish Bhatti, MD, FÂé¶¹´«Ã½Ó³»­ (University of Central Florida College of Medicine) Dr. Bhatti has nothing to disclose.